by GlobeNewsWire | Nov 12, 2015 | Globe Newswire
LEXINGTON, Mass., Nov. 12, 2015 (GLOBE NEWSWIRE) — Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced its financial and operating results for...
by GlobeNewsWire | Sep 29, 2015 | Globe Newswire
LEXINGTON, Mass., Sept. 29, 2015 (GLOBE NEWSWIRE) — Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced that it has enrolled the first patient...